Alpha-GPC improves cognitive function in mild to moderate Alzhemier's dementia.

Abstract Title: Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-​blind, randomized, placebo-​ controlled trial. 

Abstract Source: Clin Ther. 2003 Jan;25(1):178-​-93. NCBI Public Medical Research PMID: 12637119

Abstract Author(s): Maria De Jesus Moreno Moreno

CONCLUSION: The results of this study suggest the clinical usefulness and tolerability of CA in the treatment of the cognitive symptoms of dementia disorders of the Alzheimer type.


Article Published Date: Jan 01, 2003


NO RISK GUARANTEE

We are so confident in the quality of our formulation. If you are not 100% satisfied we offer a full refund.

SIGN UP TO ONNOR

Receive Early Access to Special Deals, Announcements and New Formulas